retatrutide phase 3 trial dosing schedule A Clinician's Guide to Retatrutide just delivered the most

This extended half-life supports long-lasting effects, making it a convenient option for patients who struggle with daily medication regimens

The GCGR arm adds pathways tirzepatide lacks: hepatic fatty-acid oxidation (~85–90% liver fat reduction in Phase 2a MASLD), adipose lipolysis, and thermogenic energy expenditure

Knowing when to seek medical evaluation prevents dismissing something that needs attention

so, oopsey, it was pulled from the market

BMC Medicine

If you've been following the weight loss medication space Ozempic, Wegovy, Mounjaro, Zepbound you've probably noticed a new name popping up: retatrutide